7Joint first authors: Jinghui Guo, Wenjing Wang.
Identification of serum biomarkers for pancreatic adenocarcinoma by proteomic analysis
Version of Record online: 25 AUG 2009
© 2009 Japanese Cancer Association
Volume 100, Issue 12, pages 2292–2301, December 2009
How to Cite
Guo, J., Wang, W., Liao, P., Lou, W., Ji, Y., Zhang, C., Wu, J. and Zhang, S. (2009), Identification of serum biomarkers for pancreatic adenocarcinoma by proteomic analysis. Cancer Science, 100: 2292–2301. doi: 10.1111/j.1349-7006.2009.01324.x
- Issue online: 11 NOV 2009
- Version of Record online: 25 AUG 2009
- (Received July 02, 2009/Revised August 01, 2009/Accepted August 10, 2009/Online publication September 22, 2009)
- 1Epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinoma. Gastroenterology 1999; 117: 1463–84., , .
- 2Cancer statistics 2003. CA Cancer J Clin 2003; 53: 5–26., , .
- 3Evaluation of a serologic marker, CA19–9, in the diagnosis of pancreatic cancer. Ann Intern Med 1989; 110: 704–9., , , , , .
- 4Can we screen high-risk individuals to detect early pancreatic carcinoma? J Surg Oncol 2000; 74: 243–8., , .
- 5ProteinChip surface enhanced laser desorption/ionization mass spectrometry: a novel protein biochip technology for detection of prostate cancer biomarkers in complex protein mixtures. Prostate Cancer Prostatic Dis 1999; 2: 264–76., , et al.
- 6High-resolution serum proteome features for ovarian cancer detection. Endocr Relat Cancer 2004; 11: 163–78., , et al.
- 7Quality control and peak finding for proteomics data collected from nipple aspirate fluid by surface-enhanced laser desorption and ionization. Clin Chem 2003; 49: 1615–23., , et al.
- 8Data reduction using a discrete wavelet transformation in discriminant analysis of very high dimensinality data. Biometrics 2003; 59: 143–51., , .
- 9Enrichment of low molecular weight fraction of serum for MS analysis of peptides associated with hepatocellular carcinoma. Proteomics 2006; 6: 2895–902., , et al.
- 10A data-analytic strategy for protein biomarker discovery: profiling of high-dimensional proteomic data for cancer detection. Biostatistics 2003; 4: 449–63., , et al.
- 11Recent advancements in surface-enhanced laser desorption/ionization-time of flight-mass spectrometry. Electrophoresis 2000; 21: 1164–77., .
- 12Clinical proteomics: searching for better tumour markers with SELDI-TOF mass spectrometry. Trends Pharmacol Sci 2006; 27: 251–9., , , .
- 13Use of proteomic patterns in serum to identify ovarian cancer. Lancet 2002; 359: 572–7., , et al.
- 14Identification of biomarkers for ovarian cancer using strong anion-exchange ProteinChips: potential use in diagnosis and prognosis. Proc Natl Acad Sci USA 2003; 100: 12343–8., , et al.
- 15Serum proteomic patterns for detection of prostate cancer. J Natl Cancer Inst 2002; 94: 1576–8., , et al.
- 16Diagnostic potential of serum proteomic patterns in prostate cancer. J Urol 2003; 170: 442–6., , et al.
- 17Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men. Cancer Res 2002; 62: 3609–14., , et al.
- 18Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer. Clin Chem 2002; 48: 1296–304., , , , .
- 19Pattern analysis of serum proteome distinguishes renal cell carcinoma from other urologic diseases and healthy persons. Proteomics 2003; 3: 2310–6., , , , , .
- 20Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine. Am J Pathol 2001; 158: 1491–502., , et al.
- 21Identification of hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein I as a biomarker for pancreatic ductal adenocarcinoma by protein biochip technology. Cancer Res 2002; 62: 1868–75., , et al.
- 22Serum diagnosis of pancreatic adenocarcinoma using surface-enhanced laser desorption and ionization mass spectrometry. Clin Cancer Res 2004; 10: 860–8., , et al.
- 23Prediction of pancreatic cancer by serum biomarkers using surface-enhanced laser desorption/ionization-based decision tree classification. Oncology 2005; 68: 79–86., , et al.
- 24Imaging techniques in the evaluation of adenocarcinoma of the pancreas. Dig Dis 1998; 16: 242–52., .
- 25Diagnosis of pancreatic cystic neoplasms: a report of the cooperative pancreatic cyst study. Gastroenterology 2004; 126: 1330–6., , et al.
- 26EUS in the evaluation of pancreatic cystic lesions. Gastrointest Endosc 2003; 57: 891–6., , et al.
- 27Utility of EUS in the evaluation of cystic pancreatic lesions. Gastrointest Endosc 2002; 56: 543–7., , , , , .
- 28Cystadenomas and cystadenocarcinomas of the pancreas: a multi-institutional retrospective study of 398 cases. French Surgical Association. Ann Surg 1999; 230: 152–61., , .
- 29Cystic pancreatic tumors: CT and sonographic assessment. AJR Am J Roentgenol 1988; 151: 1133–8., , , , .
- 30Can EUS alone differentiate between malignant and benign cystic lesions of the pancreas? Am J Gastroenterol 2001; 96: 3295–300., , , .
- 31Cyst fluid analysis to diagnose pancreatic cystic lesions an as yet unfulfilled promise. Gastroenterology 2006; 130: 1007–9, discussion 1009., .
- 32Molecular diagnosis of pancreatic and biliary cancer: ready for broad implementation? Cancer J 2000; 6: 282–4..
- 33Diagnostic and therapeutic approach to pancreatic cancer. Biomed Pharmacother 2000; 54: 400–9., .
- 34Protein analysis on a proteomic scale. Nature 2003; 422: 208–15., , , , .
- 35Comprehensive proteomic profiling identifies serum proteomic signatures for detection of hepatocellular carcinoma and its subtypes. Clin Chem 2003; 49: 752–60., , et al.
- 36Proteomic approaches to tumor marker discovery: identification of biomarkers for ovarian cancer. Arch Pathol Lab Med 2002; 126: 1518–26., , et al.
- 37Molecular diagnosis of solid and cystic lesions of the pancreas. Clin Lab Med 2005; 25: 101–16., , .
- 38A novel ninein-interaction protein CGI-99, blocks ninein phosphorylation by GSK3beta and is highly expressed in brain tumors. FEBS Lett 2004; 566: 162–8., , et al.
- 39Proteomic profiling in pancreatic cancer with and without lymph node metastasis. Int J Cancer 2009; 124: 1614–21., , et al.